Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock

Detailed price information for Zenas Biopharma Inc (ZBIO-Q) from The Globe and Mail including charting and trades.
Business Wire

Shift4 Announces Fourth Dividend Date for Mandatory Convertible Preferred Stock

Shift4 Payments, Inc. (“Shift4” or the “Company”) (NYSE: FOUR), announced today, in connection with the 10,000,000 shares of ...
Wall Street Journal

Columbia Convertible Securities Fund;I3

The Fund seeks total return, consisting of capital appreciation and current income. The Fund invests at least 80% of its net assets in convertible securities. The Fund may invest up to 15% of its ...

Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 Million

Jefferies, Evercore ISI, Citigroup and Guggenheim Securities are acting as joint-book running managers for the Convertible Notes Offering and Equity Offering. Wedbush PacGrow is acting as co-manager ...